Rituximab in combination with corticosteroids for the treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis: a NICE single technology appraisal.

Rituximab in combination with corticosteroids for the treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis: a NICE single technology appraisal.

Visa andra versioner (1)

As part of its single technology appraisal (STA) process, the National Institute for Health and Care Excellence (NICE) invited the manufacturer of rituximab (Roche Products) to submit evidence of the clinical and cost effectiveness of rituximab in combination with corticosteroids for treatment of an...

Full beskrivning

Bibliografiska uppgifter
Huvudupphovsmän:	Latimer, N, Carroll, C, Wong, R, Tappenden, P, Venning, M, Luqmani, R
Materialtyp:	Journal article
Språk:	English
Publicerad:	2014

Liknande verk

Rituximab in Combination with Corticosteroids for the Treatment of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: A NICE Single Technology Appraisal
av: Latimer, N, et al.
Publicerad: (2014)

Recommendations for the use of rituximab in anti-neutrophil cytoplasm antibody-associated vasculitis.
av: Guerry, M, et al.
Publicerad: (2012)

Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis?
av: Flossmann, O, et al.
Publicerad: (2006)

Successful use of rituximab for hydralazine-induced anti-neutrophil cytoplasmic antibodies-associated vasculitis
av: Michael A Paley, et al.
Publicerad: (2019-01-01)

Patient perceptions of glucocorticoids in anti-neutrophil cytoplasmic antibody-associated vasculitis
av: Robson, J, et al.
Publicerad: (2017)

Markers for work disability in anti-neutrophil cytoplasmic antibody-associated vasculitis.
av: Basu, N, et al.
Publicerad: (2014)

Global ethnic and geographic differences in the clinical presentations of anti-neutrophil cytoplasm antibody-associated vasculitis
av: Pearce, F, et al.
Publicerad: (2017)

Eosinophils in anti-neutrophil cytoplasmic antibody associated vasculitis
av: Thomas Hellmark, et al.
Publicerad: (2019-03-01)

Anti-neutrophil cytoplasmic antibody associated vasculitis following rituximab: Outcomes of 50 patients in a tertiary single centre
av: Fahidah Alenzi, et al.
Publicerad: (2023-09-01)

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis in Kidney Transplantation
av: Valentina Binda, et al.
Publicerad: (2021-12-01)

Relapse in Anti-Neutrophil Cytoplasm Antibody (ANCA)–Associated Vasculitis
av: Alan D. Salama
Publicerad: (2020-01-01)

Drug-induced anti-neutrophil cytoplasmic antibody-associated vasculitis
av: Cheng-Hua Weng, et al.
Publicerad: (2019-12-01)

A disease-specific patient-reported outcome for anti-neutrophil cytoplasmic antibody–associated vasculitis: scale structure and measurement properties of the anti-neutrophil cytoplasmic antibody-associated vasculitis patient-reported outcome measure
av: Robson, J, et al.
Publicerad: (2017)

Is rituximab “The Wonder Drug” for antineutrophil cytoplasmic antibodies-associated vasculitis?
av: Saket Jha, et al.
Publicerad: (2019-01-01)

Posterior scleritis with anti-neutrophil cytoplasmic antibody-associated vasculitis utilizing rituximab therapy to maintain remission: A case report
av: Xinyu Weng, et al.
Publicerad: (2022-03-01)

Cardiovascular and Cerebrovascular Outcomes in Anti-neutrophil Cytoplasmic Antibody-Associated Vasculitis
av: Shiyu Xiao, et al.
Publicerad: (2024-01-01)

Clonal hematopoiesis in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis
av: Christopher Maximilian Arends, et al.
Publicerad: (2020-06-01)

Anti-neutrophil cytoplasmic antibody associated vasculitis in patients with rheumatoid arthritis
av: Haiting Wu, et al.
Publicerad: (2022-04-01)

A glance into the future of anti-neutrophil cytoplasmic antibody-associated vasculitis
av: Marta Casal Moura, et al.
Publicerad: (2022-11-01)

Pathogenesis and pathology of anti-neutrophil cytoplasmic antibody（ANCA）-associated vasculitis
av: Daisuke Tsukui, et al.
Publicerad: (2021-01-01)

EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis.
av: Hellmich, B, et al.
Publicerad: (2007)

Highly Sensitive Flow Cytometric Detection of Residual B-Cells After Rituximab in Anti-Neutrophil Cytoplasmic Antibodies-Associated Vasculitis Patients
av: Laura S. van Dam, et al.
Publicerad: (2020-12-01)

Use of a computerised system to facilitate evaluation of anti-neutrophil cytoplasm (ANCA Associated) vasculitis (AAV) and other forms of systemic vasculitis
av: Luqmani, R, et al.
Publicerad: (2017)

The role of neutrophils in vasculitis associated with antineutrophil cytoplasmic antibodies
av: E. N. Vorkel, et al.
Publicerad: (2024-12-01)

Application of biological agents in the treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis
av: Weijun Liu, et al.
Publicerad: (2024-05-01)

Recent advances in the diagnosis and treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis
av: Si-wei Tang, et al.
Publicerad: (2024-03-01)

Oral Microbiota Profile in Patients with Anti-Neutrophil Cytoplasmic Antibody–Associated Vasculitis
av: Anders Esberg, et al.
Publicerad: (2022-08-01)

Late Onset of Rivaroxaban-Associated Anti-Neutrophil Cytoplasmic Antibody–Associated Vasculitis
av: Muskan Agarwal MD, et al.
Publicerad: (2023-10-01)

A case of Sjögren syndrome and anti-neutrophil cytoplasmic antibody-associated vasculitis
av: K. Kaynar, et al.
Publicerad: (2023-07-01)

Testicular granulomatous vasculitis mimicking testicular torsion in an anti-neutrophil cytoplasmic antibody–associated vasculitis patient
av: Liye Suo, et al.
Publicerad: (2019-01-01)

Clinical significance of HEp-2 cell cytoplasmic patterns in anti-neutrophil cytoplasmic antibody associated vasculitis
av: Naidan Zhang, MS, et al.
Publicerad: (2022-06-01)

Clinical features of anti-neutrophil cytoplasmic antibody-associated systemic vasculitis in French children
av: Salomon R, et al.
Publicerad: (2011-09-01)

Anti-myeloperoxidase IgM B cells in anti-neutrophil cytoplasmic antibody-associated vasculitis
av: CM Wortel, et al.
Publicerad: (2025-02-01)

Glucocorticoid Minimization in Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: An International Survey of Clinicians
av: David Massicotte-Azarniouch, et al.
Publicerad: (2024-08-01)

Remission in antineutrophil cytoplasmic antibody-associated systemic vasculitis.
av: Mukhtyar, C, et al.
Publicerad: (2006)

Severe Infections following Rituximab Treatment in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
av: Zhi-Ying Li, et al.
Publicerad: (2020-08-01)

Spotlight on rituximab in the treatment of antineutrophil cytoplasmic antibody-associated vasculitis: current perspectives
av: Moog P, et al.
Publicerad: (2015-11-01)

Neutrophil activation in patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitis and large-vessel vasculitis
av: Despina Michailidou, et al.
Publicerad: (2022-06-01)

Positive predictive value of anti-neutrophil cytoplasmic antibody (ANCA) testing for ANCA-associated systemic vasculitis (AASV) in a routine clinical setting
av: McLaren, J, et al.
Publicerad: (2001)

Anti-neutrophil cytoplasmic antibody–associated vasculitis complicated with diffuse alveolar haemorrhage and central nervous system vasculitis
av: Takashi Nawata, et al.
Publicerad: (2021-04-01)